ELECSYS PRECICONTROL CMV IGG, ELECSYS CMV IGG IMMUNOASSAY— 510(k) K131605

Substantially Equivalent

Roche Diagnostics

FDA 510(k) clearance K131605 for ELECSYS PRECICONTROL CMV IGG, ELECSYS CMV IGG IMMUNOASSAY, Substantially Equivalent on 2014-02-28. Applicant: Roche Diagnostics.

Clearance details

Applicant
Roche Diagnostics
Product code
Code LFZ
Advisory panel
Microbiology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Indianapolis, IN, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.